Inbeloral 100mg/5mg liquid Solution, Loratadine, Betamethasone
THERAPEUTIC INDICATIONS: Anti-allergic, anti-inflammatory steroid and an antihistamine.
Inbeloral is a liquid solution and is recommended when necessary adjuvant treatment with systemic corticosteroid agent for the relief of severe symptoms of atopic dermatitis, angioedema, urticaria, seasonal and perennial allergic rhinitis, food allergy and drug reactions, seborrheic dermatitis, neurodermatitis , allergic asthma, ocular allergic manifestations such as conjunctivitis and iridocyclitis and allergic reactions to insect bites.
Actions: The use of loratadine formulation + beta-metasona tablets and solution, combining anti-inflammatory and antiallergic effect of a corticosteroid (betamethasone) with a nonsedating antihistamine (loratadine).
Loratadine is a tricyclic antihistamine with potent antagonistic activity of peripheral H1 receptors.
GENERAL PRECAUTIONS: Patients with severe hepatic impairment should be given a lower dose initially, as these patients may have a slower clearance of the drug, the recommended starting dose is 5 mg once daily or 10 mg on alternate days .
May be required dose adjustments in the process of remission or exacerbation of the disease, depending on the patient's individual response to treatment and overload the patient is exposed, eg severe infection, surgery or injury. After withdrawal of long-term corticosteroid therapy or high doses, is recommended close observation of the patient up to a year.
RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION: Not established whether the administration of NS CELESTAMINE ® tablet and may represent an abnormality during pregnancy. Therefore, the drug should be used only if the potential benefit to the mother justifies the potential risk to the fetus.
It has been established that loratadine is excreted in human milk due to the potential danger of the administration of antihistamines for infants, particularly newborns and premature babies, should decide on nursing or discontinue the drug.
The use of corticosteroids in pregnancy, nursing mothers or women of childbearing age requires consideration on the one hand the risk and other potential benefits. Infants born to mothers who have received treatment with corticosteroids should be observed for signs of hypoadrenalism.